Back to results
US 7,459,448 B2Granted
Lactam compounds useful as protein kinase inhibitors
AssigneeMillennium Pharmaceuticals, Inc.
InventorsChristopher Blackburn, Christopher F. Claiborne, Courtney A. Cullis, Natalie A. Dales, Michael Patane, Matthew Stirling, Omar Stradella, Gabriel S. Weatherhead
Life of this patent
Estimating the term…
Abstract
The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Claims22
A compound of formula (I):
- or a pharmaceutically acceptable salt thereof;
- wherein:
- Ring A is an optionally substituted 5- or 6-membered aryl or heteroaryl ring;
- G1 is C═O, C═S, or S(═O)2;
- Y1 is N or CH and Y2 is N or CRe, provided that at least one of Y1 and Y2 is N;
- Ra is hydrogen, —C(O)R5a, —C(O)N(R4a)2, —CO2R6a, —SO2R6a, —SO2N(R4a)2, an optionally substituted C1-10 aliphatic, or an optionally substituted aryl, heteroaryl, or heterocyclyl ring;
- Rb is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- Rc is hydrogen, fluoro, —OR5, —N(R4)2, or an optionally substituted C1-4 aliphatic;
- Rd is hydrogen, fluoro, C1-4 aliphatic or C1-4 fluoroaliphatic;
- or Rc and Rd, taken together with the carbon atom to which they are attached, form an optionally substituted 3- to 6-membered carbocyclic ring;
- Re is hydrogen, halo, —NO2, —CN, —C(R5)═C(R5)2, —C≡C—R5, —C(R5)═C(R5)(R10), —C≡C—R10, —OR5, —N(R4)2, —NR4C(O)R5, —NR4C(O)N(R4)2, —NR4CO2R6, —CO2R5, —C(O)R5, —C(O)N(R4)2, —N(R4)SO2R6, —N(R4)SO2N(R4)2, or an optionally substituted C1-4 aliphatic;
- each R4 independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- or two R4 on the same nitrogen atom, taken together with the nitrogen atom, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatoms selected from N, O, and S;
- each R4a independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- or two R4a on the same nitrogen atom, taken together with the nitrogen atom, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatoms selected from N, O, and S;
- each R5 independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- each R5a independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- each R6 independently is an optionally substituted aliphatic or aryl group;
- each R6a independently is an optionally substituted aliphatic or aryl group;
- and
- R10 is —CO2R5 or —C(O)N(R4)2.
18 more elements
A compound of formula (V):
- or a pharmaceutically acceptable salt thereof;
- wherein:
- Ring A is substituted with 0-2 Rh and 0-2 R8h;
- Ring B is substituted with 0-2 Rj and 0-2 R8j;
- G1 is C═O, C═S, or S(═O)2;
- Y1 is N or CH;
- Y2 is N or CRe;
- Rb is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- Rc is hydrogen, fluoro, —OR5, —N(R4)2, or an optionally substituted C1-4aliphatic;
- Rd is hydrogen, fluoro, or C1-4aliphatic;
- or Rc and Rd taken together with the carbon atom to which they are attached, form an optionally substituted 3- to 6-membered carbocycic ring;
- Re is hydrogen, halo, C1-4aliphatic, C1-4fluoroaliphatic, —Re, -T3-R1e, -T3-R2e, -V2-T3-R1e, or -V2-T3-R2c;
- T3 is a C1-4alkylene chain optionally substituted with one or two R3;
- V2 is —C(R5)═C(R5)— or —C≡C—;
- R1e is an optionally substituted aryl, heteroaryl, heterocyclyl, or cycloaliphatic ring;
- R2e is —NO2, —CN, —C(R5)═C(R5)2, —C(R5)═C(R5)(R10), —C≡C—R5, —C≡C—R10, —OR5, —N(R4)2, —NR4C(O)R5, —NR4C(O)N(R4)2, —NR4CO2R6, —CO2R5, —C(O)R5, —C(O)N(R4)2, —N(R4)SO2R6, or —N(R4)SO2N(R4)2;
- each Rh independently is selected from the group consisting of C1-6aliphatic, C1-6fluoroaliphatic, halo, —R1h, —R2h, -T4-R2h, -T4-R1h, and -V3-T4-R2h, or two adjacent Rh, taken together with the intervening ring atoms, form an optionally substituted fused 4- to 8-membered aromatic or non-aromatic ring having 0-3 ring heteroatoms selected from the group consisting of O, N, and S;
- T4 is a C1-6alkylene chain optionally substituted with one or two independently selected R3a or R3b, wherein the alkylene chain optionally is interrupted by —C(R5)═C(R5)—, —C≡C—, —O—, —S—, —S(O)—, —S(O)2—, —SO2N(R4)—, —N(R4)—, —N(R4)C(O)—, —NR4C(O)N(R4)—, —N(R4)CO2—, or —SO2N(R4);
- V3 is —C(R5)═C(R5)—, —C≡C—, —O—, —S—, —S(O)—, —S(O)2—, —SO2N(R4)—, —N(R4)—, —N(R4)C(O)—, —NR4C(O)N(R4)—, —N(R4)CO2—, —C(O)N(R4)—, —C(O)—, —C(O)—C(O)—, —CO2—, —OC(O)—, —OC(O)O—, —OC(O)N(R4)—, —C(NR4)═N—, —C(OR5)═N—, —N(R4)SO2—, —N(R4)SO2N(R4)—, —P(O)(R5)—, —P(O)(OR5)—O—, —P(O)—O—, or —P(O)(NR5)—;
- each R1h independently is an optionally substituted aryl, heteroaryl, heterocyclyl, or cycloaliphatic ring;
- each R2h independently is —NO2, —CN, —C(R5)═C(R5)2, —C≡C—R5, —C(R5)═C(R5)(R10), —C≡C—R10, —OR5, —SR6, —S(O)R6, —SO2R6, —SO3R5, —SO2N(R4)2, —N(R4)2, —NR4C(O)R5, —NR4C(O)N(R4)2, —NR4COR6, —O—CO2R5, —OC(O)N(R4)2, —O—C(O)R5, —CO2R5, —C(O)—C(O)R5, —C(O)R5, —C(O)N(R4)2, —C(O)N(R4)C(═NR4)—N(R4)2, —N(R4)C(═NR4)—N(R4)—C(O), —C(═NR4)—N(R4)2, —C(═NR4)—OR5, —C(R6)═N—OR5, —N(R4)C(═NR4)—N(R4)2, —N(R4)SO2R6, —N(R4)SO2N(R4)2, —P(O)(O)R5)2;
- each Rj independently is selected from the group consisting of C1-6aliphatic, C1-6fluoroaliphatic, halo, —R1j, —R2j, -T5-R2j, -T5-R1j, -V4-T5-R1j, and -V4-T5-R2j;
- or two adjacent Rj, taken together with the intervening ring atoms, form an optionally substituted fused 4- to 8-membered aromatic or non-aromatic ring having 0-3 ring heteroatoms selected from the group consisting of O, N, and S;
- T5 is a C1-6alkylene chain optionally substituted with one or two independently selected R3a or R3b, wherein the alkylene chain optioxtally is interrupted by —C(R5)═C(R5)—, —C≡C—, —O—, —S—, —S(O)—, —S(O)2—, —SO2N(R4)—, —N(R4)—, —N(R4)C(O)—, —NR4C(O)N(R4)—, —N(R4)CO2—, —C(O)N(R4)—, —C(O)—, —C(O)—C(O)—, —CO2—, —OC(O)—, —OC(O)O—, —OC(O)N(R4)—, —N(R4)SO2—, or —SO2N(R4);
- V4 is —C(R5)═C(R5)—, —C≡C—;
- —O—, —S—, —S(O)—, —S(O)2—, —SO2N(R4)—, —N(R4)—, —N(R4)C(O)—, —OC(O)O—, —OC(O)N(R4)—, —C(NR4)═N—, —C(OR5)═N—, —N(R4)SO2—, —N(R4)SO2N(R4)—, —P(O)(R5)—, —P(O)(OR5)—O—, —P(O)—O—, or —P(O)(NR5)—N(R5)—;
- each R1j independently is an optionally substituted aryl, heteroayl, heterocyclyl, or cycloaliphatic ring;
- each R2j independently is —NO2, —CN, —C(R5)═C(R5)2, —C≡C—R5, —C(R5)═C(R5)(R10), —C≡C—R10, —OR5, —SR6, —S(O)R6, —SO2R6, —SO3R5, —SO2N(R4)2, —N(R4)2, —NR4C(O)R5, —NR4C(O)N(R4)2, —NR4CO2R6, —O—CO2R5, —OC(O)N(R4)2, —O—C(O)R5, —CO2R5, —C(O)—C(O)R5, —C(O)R5, —C(O)N(R4)2, —C(O)N(R4)C(═NR4)—N(R4)2, —N(R4)—C(═NR4)—N(R4)—C(O), —C(═NR4)—N(R4)2, —C(═NR4)—OR5, —N(R4)C(═NR4)—N(R4)2, —N(R4)SO2R6, —N(R4)SO2N(R4)2, —P(O)(R5)2, or —P(O)(OR5)2;
- each R3 independently is selected from the group consisting of C1-3aliphatic, —F, —OH, and —O(C1-3alkyl), or two substituents R3 on the same carbon atom, taken together with the carbon atom to which they are attached, form a 3- to 6-membered carbocyclic ring;
- each R3a independently is selected from the group consisting of —F, —OH, —O(C1-3alkyl), —CN, —N(R4)2, —C(O)(C1-3alkyl), —CO2H, —CO2(C1-3alkyl), —C(O)NH2, and —C(O)NH(C1-3alkyl);
- each R3b independently is a C1-3aliphatic optionally substituted with R3a or R7, or two substituents R3b on the same or adjacent carbon atom(s) taken together with the carbon atom(s) to which they are attached, form a 3- to 6-membered carbocyclic ring;
- and
- each R4 independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- or two R4 on the same nitrogen atom, taken together with the nitrogen atom, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatoms selected from N, O, and S;
- each R4a independently is hydrogen or an optionaLly substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- or two R4a on the same nitrogen atom, taken together with the nitrogen atom, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatonis selected from N, O, and S;
- each R5 independently is hydrogen or an optionallysubstituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- each R5a independently is hydrogen or an optio mally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group;
- each R6 independently is an optionally substituted aliphatic or aryl group;
- each R6a independently is an optionally substituted aliphatic or aryl group;
- each R7 independently is an optionally substituted aryl or heteroaryl ring.
- each R8h independently is selected from the group consisting of C1-4aliphatic, C1-4fluoroaliphatic, -halo, and —O(C1-4aliphatic);
- each R8j independently is selected from the group consisting of C1-4aliphatic, C1-4fluoroaliphatic, -halo, —CO2H, —CO2(C1-4aliphatic), —OH, and —O(C1-4aliphatic);
- and
- R10 is —CO02R5 or —C(O)N(R4)2.
42 more elements
Dependencies are inferred from the claim text.